Daniel D. Adams
Chairman at Protein Sciences Corp.
Profile
Daniel D.
Adams is the founder.
He founded Plant Genetic Systems International in 1982, Advanced Genetic Sciences, Inc. in 1980, Allerx, Inc. in 1989, and Biogen MA, Inc. in 1976.
Mr. Adams is also the founder of Icon Securities Corp.
Mr. Adams's current job is as the Executive Chairman at Protein Sciences Corp.
since 1995 and as the Chairman at Epivax Oncology, Inc. since 2018.
Mr. Adams's former jobs include being the Chairman at Altimmune UK Ltd.
and serving as an Independent Director at Medivation LLC (California) from 2005 to 2014.
Mr. Adams's education includes an undergraduate degree from Cornell University and a graduate degree from New York University School of Law.
Daniel D. Adams active positions
| Companies | Position | Start |
|---|---|---|
Protein Sciences Corp.
 Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Chairman | 2010-05-13 |
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Chairman | 2020-01-26 |
Former positions of Daniel D. Adams
| Companies | Position | End |
|---|---|---|
| MEDIVATION INC | Director/Board Member | 2014-10-16 |
| Advanced Genetic Sciences, Inc. | Founder | 2008-09-03 |
Icon Securities Corp.
 Icon Securities Corp. Investment Banks/BrokersFinance Part of Icon Holdings Corp., Icon Securities Corp. is a company that provides Securities Brokerage services. The company is based in New York, NY. The company was founded by Daniel D. Adams. | Founder | - |
| Allerx, Inc. | Chief Executive Officer | - |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Chairman | 2010-08-26 |
Training of Daniel D. Adams
| Cornell University | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Health Technology |
Icon Securities Corp.
Icon Securities Corp. Investment Banks/BrokersFinance Part of Icon Holdings Corp., Icon Securities Corp. is a company that provides Securities Brokerage services. The company is based in New York, NY. The company was founded by Daniel D. Adams. | Finance |
Plant Genetic Systems International
 Plant Genetic Systems International BiotechnologyHealth Technology Part of Bayer AG, Plant Genetic Systems International is a Dutch company that provides biological products. The company was founded by Daniel D. Adams. | Health Technology |
| Advanced Genetic Sciences, Inc. | Commercial Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
| Allerx, Inc. | |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Health Technology |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Daniel D. Adams
